Seeking Alpha

VolitionRX Ltd (VNRX)

  • Tue, Aug. 11, 6:32 AM
    | Tue, Aug. 11, 6:32 AM | Comment!
  • Tue, May 12, 7:53 AM
    | Tue, May 12, 7:53 AM | Comment!
  • Wed, Jan. 7, 11:44 AM
    • Thinly-traded nano cap VolitionRx (OTCQB:VNRX +21.5%) jumps on a 6x surge in volume albeit on turnover of only 39K shares. This morning, the company announced the results from a blinded clinical study that showed its NuQ diagnostic platform detected 84% of early stage surgically-treatable pancreatic cancers with 92% specificity.
    • The NuQ system identifies and measures circulating nucleosomes in the blood. It can potentially differentiate between cancer types and other conditions such as endometriosis and inflammatory diseases.
    | Wed, Jan. 7, 11:44 AM | Comment!
Visit Seeking Alpha's
VNRX vs. ETF Alternatives
Company Description
VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
Sector: Healthcare
Country: Singapore